Overview

A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers

Status:
Active, not recruiting
Trial end date:
2021-09-01
Target enrollment:
0
Participant gender:
All
Summary
This study is being done in patients that have tumors to find out how well sentinel lymph nodes (SLNs) can be found with a special dye called indocyanine green (ICG).
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Criteria
Inclusion Criteria:

- Patients <30 years old with an extracoelomic solid tumor, diagnosis confirmed at the
enrolling institution, requiring SLN biopsy

- Women of childbearing potential must have a negative pregnancy test (urine or blood)
pre-operatively as per the standard hospital policy. A woman of childbearing potential
is defined as one who is biologically capable of becoming pregnant.

- Patients who are cleared for surgery

Exclusion Criteria:

- History of reaction to ICG, iodides, or technetium radiocolloid

- Intracoelomic primary tumors or tumors expected to drain to an intracoelomic SLN

- Patients with extensive prior surgery at the primary site or nodal basin expected to
affect the lymphatic drainage

- Patients unwilling or unable to sign informed consent

- Women who are pregnant or breast-feeding